Lazar Amends OpGen Stake Filing
Ticker: CFOR · Form: SC 13D/A · Filed: Aug 1, 2024 · CIK: 1293818
| Field | Detail |
|---|---|
| Company | Opgen Inc (CFOR) |
| Form Type | SC 13D/A |
| Filed Date | Aug 1, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01, $2,450,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: schedule-13d, amendment, beneficial-ownership
Related Tickers: OPGN
TL;DR
Lazar updated his OpGen filing, watch for more details.
AI Summary
David E. Lazar has amended his Schedule 13D filing for OpGen, Inc. on July 30, 2024. This amendment, the third, indicates a change in the beneficial ownership of OpGen's common stock. The filing does not specify the exact percentage of shares owned or the dollar amount involved in this change.
Why It Matters
Changes in beneficial ownership filings like this can signal shifts in control or significant investor interest, potentially impacting the stock price.
Risk Assessment
Risk Level: medium — Schedule 13D filings often precede significant corporate actions or changes in control, introducing uncertainty.
Key Players & Entities
- David E. Lazar (person) — Filing person and potential beneficial owner
- OpGen, Inc. (company) — Subject company
- July 30, 2024 (date) — Date of event requiring filing
FAQ
What specific changes in beneficial ownership are reported in this amendment?
The filing is an amendment (Amendment No. 3) to a Schedule 13D, indicating a change in beneficial ownership, but the specific details of the change (e.g., number of shares, percentage) are not provided in the excerpt.
Who is David E. Lazar in relation to OpGen, Inc.?
David E. Lazar is identified as the person filing the Schedule 13D/A and is the subject of the filing concerning beneficial ownership of OpGen, Inc. common stock.
What is the CUSIP number for OpGen, Inc. common stock?
The CUSIP number for OpGen, Inc. common stock is 68373L406.
When was the event that required this filing to be made?
The date of the event which requires the filing of this statement is July 30, 2024.
What is the business address of OpGen, Inc.?
The business address of OpGen, Inc. is 9717 Key West Avenue, Suite 100, Rockville, MD 20850.
Filing Stats: 999 words · 4 min read · ~3 pages · Grade level 10 · Accepted 2024-08-01 17:25:39
Key Financial Figures
- $0.01 — Inc . (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securiti
- $2,450,000 — shares of Series E Preferred Stock for $2,450,000 under the SPA. The foregoing descriptio
Filing Documents
- opgen_sc13da.htm (SC 13D/A) — 36KB
- opgen_ex99-2.htm (EX-99.2) — 77KB
- 0001829126-24-005156.txt ( ) — 115KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of his knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: August 1, 2024 /s/ David E. Lazar DAVID E. LAZAR 3